KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Invested Capital (2016 - 2026)

Teladoc Health's Invested Capital history spans 14 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Invested Capital fell 32.43% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 32.43% decrease, with the full-year FY2025 number at $1.4 billion, down 32.13% from a year prior.
  • Invested Capital hit $1.3 billion in Q1 2026 for Teladoc Health, down from $1.4 billion in the prior quarter.
  • Over the last five years, Invested Capital for TDOC hit a ceiling of $9.1 billion in Q1 2022 and a floor of $1.3 billion in Q1 2026.
  • Historically, Invested Capital has averaged $2.9 billion across 5 years, with a median of $2.3 billion in 2024.
  • Biggest five-year swings in Invested Capital: crashed 85.62% in 2022 and later rose 0.79% in 2023.
  • Tracing TDOC's Invested Capital over 5 years: stood at $2.3 billion in 2022, then rose by 0.79% to $2.3 billion in 2023, then dropped by 12.22% to $2.0 billion in 2024, then tumbled by 32.13% to $1.4 billion in 2025, then dropped by 3.56% to $1.3 billion in 2026.
  • Business Quant data shows Invested Capital for TDOC at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.